Enhanced fitness of adult spermatogonial stem cells bearing a paternal age-associated FGFR2 mutation

Stem Cell Reports. 2014 Aug 12;3(2):219-26. doi: 10.1016/j.stemcr.2014.06.007. Epub 2014 Jul 17.

Abstract

Pathogenic de novo mutations increase with fathers' age and could be amplified through competition between genetically distinct subpopulations of spermatogonial stem cells (SSCs). Here, we tested the fitness of SSCs bearing wild-type human FGFR2 or an Apert syndrome mutant, FGFR2 (S252W), to provide experimental evidence for SSC competition. The S252W allele conferred enhanced FGFR2-mediated signaling, particularly at very low concentrations of ligand, and also subtle changes in gene expression. Mutant SSCs exhibited improved competitiveness in vitro and increased stem cell activity in vivo upon transplantation. The fitness advantage in vitro only occurred in low concentrations of fibroblast growth factor (FGF), was independent of FGF-driven proliferation, and was accompanied by increased response to glial cell line-derived neurotrophic factor (GDNF). Our studies provide experimental evidence of enhanced stem cell fitness in SSCs bearing a paternal age-associated mutation. Our model will be useful for interrogating other candidate mutations in the future to reveal mechanisms of disease risk.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Cells, Cultured
  • Glial Cell Line-Derived Neurotrophic Factor / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Paternal Age
  • Polymorphism, Single Nucleotide
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics*
  • Receptor, Fibroblast Growth Factor, Type 2 / metabolism
  • Spermatogonia / cytology
  • Stem Cell Transplantation
  • Stem Cells / cytology*
  • Testis / metabolism

Substances

  • Glial Cell Line-Derived Neurotrophic Factor
  • Receptor, Fibroblast Growth Factor, Type 2